Tag: FDA

63 posts found

Recalls and Alerts Impacting Workers’ Comp

The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

The ketamine molecule is not FDA-approved in any formulation for the treatment of psychiatric disorders.

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

Moderna and Pfizer boosters have been updated to target the omicron variant.

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

The public comment period is underway for this action, which could help with safer drug disposal.

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.

Wegovy (semaglutide) and sotrovimab will soon be available.

1 2 3 4 5 Next